Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    LY2940680 | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Study of Taladegib in Combination With Weekly Paclitaxel, Carboplatin, and Radiation in Localized Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Condition: Esophageal Cancer
Interventions: Drug: Taladegib;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Radiation Therapy;   Procedure: Endoscopy
2 Recruiting A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Conditions: Solid Tumor;   Breast Cancer;   Colon Cancer;   Cholangiocarcinoma;   Soft Tissue Sarcoma
Interventions: Drug: LY3039478;   Drug: Taladegib;   Drug: Abemaciclib;   Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Carboplatin;   Drug: LY3023414

Study has passed its completion date and status has not been verified in more than two years.